Product category:
Laboratory and scientific professional organisations
News Release from: The Science Advisory Board
Edited by the Laboratorytalk Editorial
Team on 26 June 2003
Snapshots on cytokines and growth
factors
Live teleconference this month discussed technical aspects and capabilities of cytokines and growth factors; record can be downloaded as an MP3 file
The Science Advisory Board held its third live teleconference, 'Snapshots Live on Cytokines and Growth Factor Kits and Reagents' on 11 June 2003 The teleconference joined together members of the Science Advisory Board who participated in a cytokine and growth factor study
This article was originally published on Laboratorytalk on 8 May 2003 at 8.00am (UK)
Related stories
Cancer treatment hopefuls: cytokine cures
Just over half of respondents in a recent survey believe that cytokines will make cancer cells more susceptible to destruction by the immune response
Download a conversation on tissue microarrays
MP3 file of 30-minute teleconference on tissue microarrays provides information on products and techniques most commonly employed by scientists
The 30-minute teleconference featured a brief online presentation of the results from the Science Advisory Board-sponsored study by an in-house team of analysts.
An MP3 of the teleconference, along with a Power Point presentation can be accessed through The Science Advisory Board's webpage.
By listening to this Snapshots Live recording, visitors can learn more about the technical aspects and capabilities of cytokines and growth factors.
Cytokines and growth factors are small, multifunctional proteins that play critical roles in controlling development and in regulating the body's responses to disease and infection.
Among the clinical applications for cytokine and growth factor research are cancer immunotherapy, wound healing, allergy relief, animal health, treatment of autoimmune disorders, anti-viral therapy, obesity, and disease diagnosis.
Although cytokines and growth factors have been studied for many years, these molecules are taking on new importance for two main reasons.
Sequencing of the human genome has revealed a variety of potential new drug targets that are related to previously characterised cytokines, growth factors and receptors, and the drug development pipelines of many pharmaceutical companies contain growing numbers of cytokine, growth factor and receptor-based protein drugs, antibodies and small molecule inhibitors.
Future Snapshots Live events include discussions on microbial genotyping and tissue microarrays.
• The Science Advisory Board: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
